Gujarat Magazine

Non-Opioid Pain Patches Market Details 2021: Top-Level Companies, Present Market Dynamics and Future Advancements 2027

 Breaking News
  • No posts were found

Non-Opioid Pain Patches Market Details 2021: Top-Level Companies, Present Market Dynamics and Future Advancements 2027

August 04
14:35 2021
Non-Opioid Pain Patches Market Details 2021: Top-Level Companies, Present Market Dynamics and Future Advancements 2027

Non-Opioid Pain Patches Market
The non-opioid pain patches available in the market include capsaicin patches, methyl salicylate patches, diclofenac patches, ketoprofen patches, and lidocaine patches. The lidocaine patches hold a major market share on account of their proven efficacy and safety profile.

Non-Opioid Pain Patches Market Scenario:

The latest market report published by Straits Research, titled ‘Global Non-Opioid Pain Patches Market,’ medications also have other therapeutic applications, such as analgesic, anti-inflammatory, and antipyretic actions. Globally, the rising prevalence of acute and chronic pain-related disorders is subsequently increasing the demand for non-opioid pain patches. As per the U.S. Department of Health and Human Services, pain-related disorders are the most common causes of patients visiting healthcare facilities, which is further increasing healthcare expenditure.

Get a Sample Copy of this report with the latest Industry trends and COVID-19 Impact:  https://straitsresearch.com/report/Non-Opioid Pain Patches-Market/request-sample

The Major Players Covered in this Report: Acorda Therapeutics, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Endo Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., IBSA Institute Biochimque, Teikoku Seiyaku Co. Ltd., Mylan N.V., Allergan, Co., and Teh Seng Pharmaceutical Mfg., & more…

Non-Opioid Pain Patches Market Segmentation:
By Patch Type: Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others

By Distribution Channel: Hospitals, Online Pharmacies, Drug Stores, Others

Years that have been considered for the study of this report are as follows: 

  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year: 2021 to 2027

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/non-opioid-pain-patches-market/global/

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Non-Opioid Pain Patches in the APAC Region:
Asia-Pacific region is anticipated to hold the largest market share in the global Non-Opioid Pain Patches market during the forecast period 2021-2027. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Non-Opioid Pain Patches and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Non-Opioid Pain Patches. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

Full Report Link @ https://straitsresearch.com/report/Non-Opioid Pain Patches-Market 

Which Segment will Dominate the Market?
By type, the non-opioid pain patches market is segmented into lidocaine, diclofenac, methyl salicylate, capsaicin, and ketoprofen patches. All of the above-mentioned patches are utilized for mitigating chronic and acute pain without causing any sort of addiction. It is extensively used for the treatment of respiratory depression, androgen deficiency, nausea, vomiting, constipation, GI disturbances, and physical dependence. The lidocaine patches are most commonly available for the treatment of acute and chronic pain as they are safe and efficient. It is also prescribed as a first-line treatment of neuropathic pain in geriatrics and those suffering from shingles. Recently, IBSA Institute Biochimique SA developed a Flector patch, which is a type of diclofenac patch that aids patients in the management of acute and intense pain. Similarly, Alpharmaca Pharmaceuticals LLC acquired the license to develop and market diclofenac patches.

Would you like to discuss Non-Opioid Pain Patches Market challenges with the experts at Straits Research?

Media Contact
Company Name: Straitsresearch
Contact Person: Riya
Email: Send Email
Phone: 6464807505
Address:825 3rd Avenue New York, NY, USA, 10022
City: New York
State: United States
Country: United States
Website: https://straitsresearch.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/haridwartoday/gujaratmagazine.in/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share

Recent Posts

Post-Traumatic Stress Disorder (PTSD) Clinical and Non-Clinical Studies, Therapeutic Pipeline Assessment, and Emerging Therapies | Key Companies Include – Aptinyx, Otsuka, Nobilis, Bionorica & Others

Read Full Article

Categories